Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemia.
Canaani J, Nagar M, Heering G, Gefen C, Yerushalmi R, Shem-Tov N, Volchek Y, Merkel D, Avigdor A, Shimoni A, Amariglio N, Rechavi G, Nagler A.
Canaani J, et al. Among authors: volchek y.
Oncotarget. 2020 Jun 9;11(23):2233-2245. doi: 10.18632/oncotarget.27618. eCollection 2020 Jun 9.
Oncotarget. 2020.
PMID: 32577167
Free PMC article.